Strasbourg, January 7, 2025 – 06:00 pm CET
Under the liquidity contract entrusted by Transgene to Natixis Oddo BHF SCA, as of December 31, 2024, the following resources were managed through the liquidity account:
In the second half of 2024, a total of:
Purchases | 250,777 shares | € 243,947.38 | 1,154 market transactions |
Sales | 229 905 shares | € 230,275.17 | 1,081 market transactions |
It is recalled that when the liquidity program was initially established in 2016, the following resources were made available:
At the time the liquidity program was transferred to Natixis Oddo BHF SCA on January 2, 2020, the resources managed through the liquidity account consisted of:
Contacts
Transgene: Lucie LARGUIER CFO +33 (0)3 88 27 91 00 investorrelations@transgene.fr |
Attachment
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。